Is this your brand? Sign in to claim ownership.
Sign in to claim this brandHelena Laboratories, Corp.
US
Last updated September 17, 2026
About
Helena Laboratories provides quality products and services to customers worldwide. Our products include electrophoresis analyzers and supplies, densitometers, hemostasis reagents and instruments, immunology and protein diagnostic systems, disposable laboratory plasticware, fecal occult blood test kits, and a wide range of additional laboratory solutions.
From the manufacturer's own website. Source
What Helena Laboratories, Corp. makes
Helena Laboratories manufactures in vitro diagnostic devices including protein electrophoresis kits and reagents, faecal occult blood test kits, platelet aggregation study reagents, coagulation analyzers, densitometry analyzers, and electrophoresis analyzers.
The company's products are classified as Class I and Class II medical devices and are listed in the FDA Unique Device Identification (UDI) registry. Helena Laboratories is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What medical devices does Helena Laboratories manufacture?
Helena Laboratories manufactures in vitro diagnostic devices including protein electrophoresis kits and reagents, faecal occult blood test kits, platelet aggregation study reagents, coagulation analyzers, densitometry analyzers, and electrophoresis analyzers.
Where is Helena Laboratories based?
Helena Laboratories is based in the United States, as indicated by the country information provided in the device data.
Which regulatory registries list Helena Laboratories' devices?
Helena Laboratories' devices are listed in the FDA Unique Device Identification (UDI) registry, as specified in the device data.
How are Helena Laboratories' devices classified?
Helena Laboratories' devices are classified as Class I and Class II medical devices, according to the device classification information provided.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- 1530 Lindbergh Dr, BEAUMONT, TX, 77707
- Website
- www.helena.com
- facebook.com/HelenaLaboratories
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- 1618982
- DUNS Number
- —
Catalogue (662)
Page 10 of 14| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Titan Gel Ife Free Kappa/Lamba Light Chain Antiser | K891683 | FDA 510(k) | Class II | Active |
| Titan Gel Ife Antiserum To Igd-9409 & Ige-9410 | K872834 | FDA 510(k) | Class II | Active |
| Pentavalent Antiserum To Human Immunoglobulins | K871352 | FDA 510(k) | Class II | Active |
| Rep Cholesterol Profile Kit | K992971 | FDA 510(k) | Class I | Active |
| Rep Glyco Control Normal(3209) And Abnormal(3210) | K900017 | FDA 510(k) | Class II | Active |
| Free Protein S Reagent Cat. No. 5363 | K904247 | FDA 510(k) | Class II | Active |
| Kemtrol Serum Control-Normal | K802108 | FDA 510(k) | Class I | Active |
| Rep Hemoglobin Ief Kits (cat. No. 3250) | K901143 | FDA 510(k) | Class II | Active |
| Cascase 480 Snslyzer | K951497 | FDA 510(k) | Class II | Active |
| Fetal-Tek Control Mature | K820319 | FDA 510(k) | Class I | Active |
| Rep 3 Flur Spe-60 Kit | K964453 | FDA 510(k) | Class I | Active |
| Helena Thromboplastin-Mi Reagent | K940310 | FDA 510(k) | Class II | Active |
| Spife Cholesterol Profile Kit | K000603 | FDA 510(k) | Class I | Active |
| Helena Glycosylated Hemoglobin Quik Meth | K800857 | FDA 510(k) | Class II | Active |
| SPIFE A1AT kit | K213396 | FDA 510(k) | Class II | Active |
| Helena Coloscreen | K792655 | FDA 510(k) | Class II | Active |
| Lyophilized G-Hb Quik Column Control | K791135 | FDA 510(k) | Class II | Active |
| Rep Spe-8 Kit, Cat.# 3172/Rep Spe-16 Kit Cat.#3171 | K893211 | FDA 510(k) | Class I | Active |
| Helena Fetal-Tek 200 Method | K811588 | FDA 510(k) | Class II | Active |
| Rep Hdl/Ldl-30 Kit - Cat. No. 3220, 3221, 3222 | K940679 | FDA 510(k) | Class I | Active |
| Helena Hemoglobin Detect Column Sys | K820573 | FDA 510(k) | Class II | Active |
| Helena Hemespec Ii Total Hemoglobin Met. | K803016 | FDA 510(k) | Class II | Active |
| Cardio Rep Ld Control - Cat No. 3325 | K950801 | FDA 510(k) | Class I | Active |
| Protein S Antigen Rocket Eid Kit, Cat. No. 5359 | K896174 | FDA 510(k) | Class II | Active |
| Bufferizer | K791144 | FDA 510(k) | Class I | Active |
| Rep(tm) Spe Plus-16 (ponceau S) And (amido) | K901463 | FDA 510(k) | Class I | Active |
| Rep Cholesterol Profile Control-Ii | K974609 | FDA 510(k) | Class I | Active |
| Cardio Rep Ck Calibrators 1 & 2 Cat. No. 3322 & 3323 | K932768 | FDA 510(k) | Class II | Active |
| Cascade 480 | K921363 | FDA 510(k) | Class II | Active |
| Hemespec Ii | K803015 | FDA 510(k) | Class II | Active |
| Helena Abnormal Hba2 Quik Column Control | K820787 | FDA 510(k) | Class II | Active |
| Helena Factor V Deficient Substrate | K792507 | FDA 510(k) | Class II | Active |
| Kemtrol Serum Control-Abnormal | K920926 | FDA 510(k) | Class I | Active |
| Factor Viii Related Antigen Rocket Eid | K823267 | FDA 510(k) | Class II | Active |
| Actalyke Xl Activated Clotting Time Analyzer, Model 5770 | K020914 | FDA 510(k) | Class II | Active |
| Helena Rep Gel Processor | K882163 | FDA 510(k) | Class I | Active |
| Rep(r) Spe Template 30, 16, & 8 | K913807 | FDA 510(k) | Class I | Active |
| Helena Ristocetin | K800432 | FDA 510(k) | Class II | Active |
| Titan Gel Rep Ldh-12 Hv | K874143 | FDA 510(k) | Class II | Active |
| Aves Wright Stain | K820437 | FDA 510(k) | Class I | Active |
| Spife Ife Calibrator And Control Kit | K010617 | FDA 510(k) | Class II | Active |
| Collagen Reagent Cat. No. 5368 | K910706 | FDA 510(k) | Class II | Active |
| Modification Columnmate | K920820 | FDA 510(k) | Class II | Active |
| Helena Sickle-Thal Quik Column Method | K812077 | FDA 510(k) | Class II | Active |
| Hemespec Check Set | K800852 | FDA 510(k) | Class II | Active |
| Chrom-Trol Cat. No. 5300 W/ New Analyte | K902083 | FDA 510(k) | Class II | Active |
| Kemtrol Serum Control Abnormal | K802109 | FDA 510(k) | Class I | Active |
| Titan Gel Lipoprotein Electrophoresis | K833611 | FDA 510(k) | Class I | Active |
| Epinephrine Reagent, Cat. No. 5367 | K910680 | FDA 510(k) | Class II | Active |
| Helena Thromboplastin Reagent | K892050 | FDA 510(k) | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (16)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Helena Laboratories, Corp. has 16 recall records initiated between 2016-04-20 and 2023-05-02, with statuses recorded as open, classified, and terminated. The reasons for recall include issues such as enzyme activity not being in range, particulate matter or microbial growth in reagents, mislabeled internal components, assay range variations, variations in test results, positive control reactivity issues, cracked test tube caps, and missing wells in plates.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| May 2, 2023 | Z-1975-2023 | — | open, classified | Packaging for a serrated blade applicator kit (12 Sample) may contain a serrated blade applicator (18 sample). This results in a characteristic pattern of missed or light samples on the gel, leading to incorrect or no result, or delay in result. |
| Apr 6, 2022 | Z-1244-2022 | — | open, classified | Due to microbial growth causing interference with interpretation. |
| Jan 5, 2021 | Z-1108-2021 | — | terminated | Intermittent potential for shorter than expected clot times. |
| Nov 9, 2020 | Z-0635-2021 | — | open, classified | Due to complaints received associated with cracked/split test tube caps. |
| Aug 8, 2018 | Z-1950-2019 | — | open, classified | The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning correctly. |
| Aug 8, 2018 | Z-1949-2019 | — | open, classified | The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning correctly. |
| May 23, 2018 | Z-0536-2020 | — | open, classified | Through an investigation, it has been determined that vials of Collagen packaged within the Collagen Reagent and Platelet Aggregation Kit may contain particulate matter or microbial growth. |
| May 23, 2018 | Z-0537-2020 | — | open, classified | Through an investigation, it has been determined that vials of Collagen packaged within the Collagen Reagent and Platelet aggregation Kit, may contain particulate matter or microbial growth. |
| Feb 27, 2018 | Z-0297-2020 | — | open, classified | Lots of gel kits contained a newer revision of the Customer Procedures instructions than intended. The incorrect inserts refer to updated parameters associated with new electrodes -- which have not yet been made available to users. |
| Dec 7, 2017 | Z-2761-2019 | — | terminated | Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the screening assay. |
| Jul 21, 2017 | Z-0045-2020 | — | terminated | The plates do not have wells punched for the controls in the patient 1 area. |
| Apr 4, 2017 | Z-0106-2019 | — | terminated | Internal components of the Protein S ELISA Antigen Kit (Lot: 3-16-5292) were mislabeled. The Protein S Conjugate Solution is labeled as Substrate, and the Substrate is labeled as Protein S conjugate. |
| Feb 24, 2017 | Z-0561-2019 | — | terminated | Due to some cards in this lot reported to have experienced variations in results, (verified by wave form), resulting in some cards with shorter or longer times than expected. |
| Nov 7, 2016 | Z-0529-2019 | — | terminated | Due to a customer experiencing complaints on bone fraction of assay not being in range. The complaint: ~12% lower enzyme activity was noted. |
| Oct 14, 2016 | Z-2434-2019 | — | terminated | Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range. |
| Apr 20, 2016 | Z-0594-2019 | — | terminated | Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected |